Investors will be watching what information UnitedHealth shares related to COVID-19 medical costs, including testing and hospitalizations, as well as how the cancellation of nonemergency care is reflected in the healthcare giant’s results. However, COVID-19 medical costs aren’t expected to significantly affect UnitedHealth’s first-quarter results, since COVID-19 testing and infections became much more prevalent late in the quarter in March, according to the report.
In a note to clients cited by CNBC, analysts at Piper Sandler said early data on medical claims may be unclear, as “much of the claims processing/coding teams [are] now working from home at hospitals and insurers,” which could slow normal revenue cycle processes.
UnitedHealth is expected to report adjusted earnings of $3.63 per share on $64.4 billion in revenue for the first quarter of 2020, according to CNBC, which cites an estimate from Refinitiv.
More articles on healthcare finance:
105 hospitals furloughing workers in response to COVID-19
Mayo Clinic projects $900M shortfall, implements cost-cutting measures
State-by-state breakdown of 354 rural hospitals at high risk of closing
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
